S.VinothapooshanG
Most clients experience minimal side effects, such as mild soreness, redness, or bruising at the injection site
Najmi A, Wang S, Huang Y, Seefeldt T, Alqahtani Y, Guan X
Given that some mutant enzymes retain low-level FAD-binding capacity, a gene + high-dose riboflavin synergy strategy has been proposed: in AIFM1 encephalopathies, low-level AAV transduction re-establishes baseline protein expression, while daily riboflavin doses above 400 mg act as a molecular chaperone to stabilize FAD binding a regimen shown to improve ICARS scores and neuroimaging outcomes (54, 75)
(2017) 'Efficacy of glutathione for NAFLD', BMC Gastroenterology , 17, 96